Home › Funds › Venrock Adviser, LLC › ARTV
Venrock Adviser, LLC position in ARTV
ARTIVA BIOTHERAPEUTICS INC · Health Care
Venrock Adviser, LLC reported holding 2,043,596 shares of ARTV (ARTIVA BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$14.6M, representing 0.71% of its reported portfolio and ranking #29 among its reported holdings. Venrock Adviser, LLC has disclosed ARTV holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Venrock Adviser, LLC's ARTV position evolved
Venrock Adviser, LLC first disclosed a stake in ARTV in Q3 2024 at 1,609,569 shares (US$24.9M). Across 9 filings, Venrock Adviser, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 2,043,596 shares valued at US$14.6M. Notable position changes include a 27% increase in Q2 2026 (shares fell 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 1.61M | $24.87M | New |
| Q4 2024 | 1.61M | $16.22M | Hold |
| Q1 2025 | 1.61M | $4.83M | Hold |
| Q2 2025 | 1.61M | $2.43M | Hold |
| Q3 2025 | 1.61M | $4.62M | Hold |
| Q4 2025 | 1.61M | $6.91M | Hold |
| Q1 2026 | 1.61M | $10.37M | Hold |
| Q2 2026 | 2.04M | $19.82M | Add |
| Q3 2026 | 2.04M | $14.55M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ARTV and 13F data
ARTV (ARTIVA BIOTHERAPEUTICS INC) is a Health Care company. 87 other funds we track also report a position in ARTV — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$220.2M), 5AM Venture Management, LLC (US$139.1M), Deep Track Capital, LP (US$73.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ARTV
- RA CAPITAL MANAGEMENT, L.P. 23.79M sh · $220.20M · Q3 2026
- 5AM Venture Management, LLC 9.68M sh · $139.10M · Q3 2026
- Deep Track Capital, LP 4.41M sh · $73.62M · Q3 2026
- Blue Owl Capital Holdings LP 4.13M sh · $63.84M · Q3 2026
- Foresite Capital Management V, LLC 3.56M sh · $59.50M · Q3 2026
- Foresite Capital Management VI LLC 2.20M sh · $36.80M · Q3 2026
- Cormorant Asset Management, LP 1.82M sh · $30.32M · Q3 2026
- ORBIMED ADVISORS LLC 1.68M sh · $27.98M · Q3 2026
- Sanofi 672.78K sh · $11.24M · Q3 2026
- Caligan Partners LP 1.48M sh · $10.55M · Q3 2026
- Samsara BioCapital, LLC 954.86K sh · $6.80M · Q3 2026
- Saturn V Capital Management LP 300.36K sh · $5.02M · Q3 2026
More on Venrock Adviser, LLC
FAQ
How long has Venrock Adviser, LLC held ARTV?
Venrock Adviser, LLC has disclosed ARTV holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Venrock Adviser, LLC's current position in ARTV?
As of Q3 2026, Venrock Adviser, LLC holds 2.04M shares of ARTV (ARTIVA BIOTHERAPEUTICS INC), valued at $14.55M, representing 0.71% of its reported portfolio and ranking #29.
Has Venrock Adviser, LLC been buying or selling ARTV?
In the latest 13F filing (Q3 2026), Venrock Adviser, LLC held unchanged its position in ARTV.
Which other funds hold ARTV?
Other major institutional holders of ARTV include RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, Deep Track Capital, LP, among 87 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.